/Companies

Jupiter Neurosciences, Inc.

NASDAQ: JUNS

1 known investors

Find your way into Jupiter Neurosciences, Inc.

Sign up to see every warm intro you have to Jupiter Neurosciences, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Jupiter Neurosciences, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Jupiter Neurosciences is a biopharmaceutical company developing JOTROL, a patented micellar oral formulation of resveratrol designed to cross the blood-brain barrier for central nervous system treatment. Its focus is developing therapies for Alzheimer's disease and rare "orphan" diseases.

Founders & leadership

CR
Christer RosénChairman, CEO & FounderChief Executive Officer and President at Jupiter Orphan Therapeutics
MH
Marshall HaywardChief Scientific Officer and Director
AD
Alison D. SilvaPresident and Chief Operating Officer, and Director
AR
Alexander RosénChief Administrative OfficerChief Administrative Officer at Jupiter Orphan Therapeutics

Investors · 1

Funding

SEC filings, press & company announcements
  • Undisclosed amountRegistered Direct OfferingAug 2026
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Valuation · disclosed

Disclosed events
$131.5Mvaluation at IPODec 2024 · $4.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

In the news

Frequently asked questions

What does Jupiter Neurosciences, Inc. do?
Jupiter Neurosciences is a biopharmaceutical company developing JOTROL, a patented micellar oral formulation of resveratrol designed to cross the blood-brain barrier for central nervous system treatment. Its focus is developing therapies for Alzheimer's disease and rare "orphan" diseases.
Who founded Jupiter Neurosciences, Inc.?
Jupiter Neurosciences, Inc. was founded by Christer Rosén, Marshall Hayward.
Who are Jupiter Neurosciences, Inc.'s investors?
Jupiter Neurosciences, Inc.'s investors include Tarnagulla Ventures.